BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28939028)

  • 1. SRC activates TAZ for intestinal tumorigenesis and regeneration.
    Byun MR; Hwang JH; Kim AR; Kim KM; Park JI; Oh HT; Hwang ES; Hong JH
    Cancer Lett; 2017 Dec; 410():32-40. PubMed ID: 28939028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
    Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis.
    Lamar JM; Xiao Y; Norton E; Jiang ZG; Gerhard GM; Kooner S; Warren JSA; Hynes RO
    J Biol Chem; 2019 Feb; 294(7):2302-2317. PubMed ID: 30559289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of the Wnt/β-catenin pathway.
    Zhang QQ; Zhou DL; Lei Y; Zheng L; Chen SX; Gou HJ; Gu QL; He XD; Lan T; Qi CL; Li JC; Ding YQ; Qiao L; Wang LJ
    Oncotarget; 2015 Feb; 6(5):3123-35. PubMed ID: 25605242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells.
    Diamantopoulou Z; White G; Fadlullah MZH; Dreger M; Pickering K; Maltas J; Ashton G; MacLeod R; Baillie GS; Kouskoff V; Lacaud G; Murray GI; Sansom OJ; Hurlstone AFL; Malliri A
    Cancer Cell; 2017 May; 31(5):621-634.e6. PubMed ID: 28416184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Src drives intestinal regeneration and transformation.
    Cordero JB; Ridgway RA; Valeri N; Nixon C; Frame MC; Muller WJ; Vidal M; Sansom OJ
    EMBO J; 2014 Jul; 33(13):1474-91. PubMed ID: 24788409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling.
    Wang S; Englund E; Kjellman P; Li Z; Ahnlide JK; Rodriguez-Cupello C; Saggioro M; Kanzaki R; Pietras K; Lindgren D; Axelson H; Prinz CN; Swaminathan V; Madsen CD
    Nat Cell Biol; 2021 Jul; 23(7):758-770. PubMed ID: 34226698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.
    Shanzer M; Ricardo-Lax I; Keshet R; Reuven N; Shaul Y
    Oncogene; 2015 Aug; 34(32):4190-8. PubMed ID: 25362852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression.
    Talla SB; Brembeck FH
    Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.
    Vu T; Datta A; Banister C; Jin L; Yuan G; Samuel T; Bae S; Eltoum IE; Manne U; Zhang B; Welner RS; Mitra K; Buckhaults P; Datta PK
    Gastroenterology; 2022 Jan; 162(1):193-208. PubMed ID: 34520730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
    Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
    Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.
    Moran AE; Hunt DH; Javid SH; Redston M; Carothers AM; Bertagnolli MM
    J Biol Chem; 2004 Oct; 279(41):43261-72. PubMed ID: 15294912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periostin Promotes Colorectal Tumorigenesis through Integrin-FAK-Src Pathway-Mediated YAP/TAZ Activation.
    Ma H; Wang J; Zhao X; Wu T; Huang Z; Chen D; Liu Y; Ouyang G
    Cell Rep; 2020 Jan; 30(3):793-806.e6. PubMed ID: 31968254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of SRC oncogenic signaling in colorectal cancer by stable isotope labeling with heavy amino acids in mouse xenografts.
    Sirvent A; Vigy O; Orsetti B; Urbach S; Roche S
    Mol Cell Proteomics; 2012 Dec; 11(12):1937-50. PubMed ID: 23023324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133-Src-TAZ signaling stimulates ductal fibrosis following DDC diet-induced liver injury.
    Oh HT; Heo W; Yoo GD; Kim KM; Hwang JH; Hwang ES; Ko J; Ko YG; Hong JH
    J Cell Physiol; 2022 Dec; 237(12):4504-4516. PubMed ID: 36250997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
    Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
    Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.